Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission

Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission

Abstract Background Phosphodiesterase 10A (PDE10A) is an important regulator of nigrostriatal dopamine (DA) neurotransmission. However, little is known on the effect of alterations in DA neurotransmission on PDE10A availability. Here, we used [18F]JNJ42259152 PET to measure changes in PDE10A availab...

Full description

Bibliographic Details
Main Authors: Maarten Ooms, Sofie Celen, Ronald De Hoogt, Ilse Lenaerts, Johnny Liebregts, Greet Vanhoof, Xavier Langlois, Andrey Postnov, Michel Koole, Alfons Verbruggen, Koen Van Laere, Guy Bormans
Format: Article
Language:English
Published: SpringerOpen 2016-03-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Phosphodiesterase 10A
Dopamine neurotransmission
D-amphetamine
Small animal PET
Brain imaging
Online Access:http://link.springer.com/article/10.1186/s41181-016-0005-5

Internet

http://link.springer.com/article/10.1186/s41181-016-0005-5

Similar Items